Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy

被引：0
|
作者：
Lan-Lan Pang
Jia-Di Gan
Yi-Hua Huang
Jun Liao
Wei-Tao Zhuang
Wael-Abdullah-Sultan Ali
Shao-Dong Hong
Li Zhang
Wen-Feng Fang
机构：
[1] Sun Yat-Sen University Cancer Center,Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
来源：
BMC Cancer | / 23卷
关键词：
Non-small cell lung cancer; Immunotherapy; Chemotherapy; Combination; Antiangiogenic agents; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Role of antiangiogenic agents in first-line treatment for advanced NSCLC in the era of immunotherapy
    Pang, Lan-Lan
    Gan, Jia-Di
    Huang, Yi-Hua
    Liao, Jun
    Zhuang, Wei-Tao
    Ali, Wael-Abdullah-Sultan
    Hong, Shao-Dong
    Zhang, Li
    Fang, Wen-Feng
    BMC CANCER, 2023, 23 (01)
  • [2] Immunotherapy in the First-Line Setting of Advanced NSCLC
    Herbst, Roy
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S107 - S108
  • [3] Treatment options after first-line immunotherapy in metastatic NSCLC
    Santos, Edgardo S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (03) : 221 - 228
  • [4] Optimizing first-line treatment options for patients with advanced NSCLC
    Wakelee, H
    Belani, CP
    ONCOLOGIST, 2005, 10 : 1 - 10
  • [5] The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer
    Spagnuolo, Alessia
    Gridelli, Cesare
    CANCERS, 2023, 15 (08)
  • [6] Paclitaxel Liposome Combined with Immunotherapy in the First-Line Treatment of Advanced NSCLC: A Multicenter Real-World Study
    Jiang, L.
    Zheng, D.
    Ni, J.
    Ding, H.
    Zhao, Y.
    Heng, W.
    Shang, Y.
    Cai, X.
    Yan, J.
    Wang, J.
    Guo, J.
    Tan, X.
    Hong, X.
    Zhang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S248 - S249
  • [7] Patterns of Failure and Subsequent Treatment after Progression on First-Line Immunotherapy Monotherapy in Advanced NSCLC
    Deng, J-Y.
    Yang, M-Y.
    Yang, X-R.
    Xu, C-R.
    Zhou, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S596 - S597
  • [8] Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
    Bogani, G.
    Monk, B. J.
    Powell, M. A.
    Westin, S. N.
    Slomovitz, B.
    Moore, K. N.
    Eskander, R. N.
    Raspagliesi, F.
    Barretina-Ginesta, M. -P
    Colombo, N.
    Mirza, M. R.
    ANNALS OF ONCOLOGY, 2024, 35 (05) : 414 - 428
  • [9] Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer
    Wang, Guocheng
    Huang, Yan
    Zhou, Liang
    Yang, Haojun
    Lin, Huang
    Zhou, Shengfang
    Tan, Zhengang
    Qian, Jun
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 198
  • [10] Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients
    Grenda, Anna
    Iwan, Ewelina
    Kuznar-Kaminska, Barbara
    Bomba, Arkadiusz
    Bielinska, Katarzyna
    Krawczyk, Pawel
    Chmielewska, Izabela
    Frak, Malgorzata
    Szczyrek, Michal
    Rolska-Kopinska, Anna
    Jankowski, Tomasz
    Kieszko, Robert
    Milanowski, Janusz
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345